Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Deafness
ADR ID BADD_A01156
ADR Hierarchy
04      Ear and labyrinth disorders
04.02      Hearing disorders
04.02.01      Hearing losses
04.02.01.001      Deafness
Description A general term for the complete loss of the ability to hear from both ears. [MeSH]
MedDRA Code 10011878
MeSH ID D003638; D034381
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Deaf | Deafness | Deafness NOS | Hearing loss | High frequency deafness | Low frequency deafness | No hearing | Other specified forms of deafness | Other specified forms of hearing loss | Unspecified deafness | Unspecified hearing loss | Deafness (NOS) | Deafness total | Surdity | Deafness toxic | Complete hearing loss | Cophosis | Deafness, Acquired | Acquired Deafness | Hearing Loss, Extreme | Extreme Hearing Loss | Deaf Mutism | Deaf-Mutism | Hearing Loss, Complete | Complete Hearing Loss | Bilateral Deafness | Deafness, Bilateral | Prelingual Deafness | Deafness, Prelingual
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02329Valproic acid0.001148%
BADD_D02331Valsartan0.000397%
BADD_D02332Vancomycin--
BADD_D02333Vancomycin hydrochloride--
BADD_D02337Varenicline0.000389%
BADD_D02338Varenicline tartrate--
BADD_D02345Venetoclax0.000280%
BADD_D02346Venlafaxine0.000064%
BADD_D02355Vigabatrin--
BADD_D02358Vinblastine--
BADD_D02359Vinblastine sulfate--
BADD_D02360Vincristine--
BADD_D02364Vinorelbine tartrate--
BADD_D02365Vismodegib0.000604%
BADD_D02367Voltaren--
BADD_D02369Voriconazole0.014521%
BADD_D02371Vortioxetine0.000296%
BADD_D02375Water--
BADD_D02378Zalcitabine--
BADD_D02379Zaleplon--
BADD_D02383Zidovudine--
BADD_D02392Zoledronic acid0.007157%
BADD_D02394Zolpidem0.000051%
BADD_D02396Zonisamide--
BADD_D02412Octreotide--
BADD_D02436Atorvastatin--
BADD_D02440Lisdexamfetamine--
BADD_D02443Tiotropium--
BADD_D02452Icatibant-
BADD_D02464Fingolimod0.002990%
The 12th Page    First    Pre   12 13    Next   Last    Total 13 Pages